Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) insider David Malcom Rodman sold 416 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $31.33, for a total transaction of $13,033.28. Following the completion of the sale, the insider directly owned 69,792 shares in […]

Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) SVP Nathalie Dubois-Stringfellow sold 345,942 shares of Sangamo Therapeutics stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $0.26, for a total transaction of $89,944.92. Following the transaction, the senior vice president owned 332,769 shares in the company, valued […]

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason Rhodes sold 274,297 shares of the stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $19.52, for a total value of $5,354,277.44. Following the sale, the director directly owned 13,148 shares of the company’s stock, […]

Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) Director Orbimed Advisors Llc sold 52,397 shares of the business’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $44.68, for a total transaction of $2,341,097.96. Following the completion of the sale, the director owned 2,967,722 shares […]

Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) insider David Malcom Rodman sold 14,058 shares of the business’s stock in a transaction that occurred on Monday, April 13th. The stock was sold at an average price of $26.54, for a total value of $373,099.32. Following the transaction, the insider directly owned 76,140 shares in the […]

Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the business’s stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $82.58, for a total transaction of $1,651,600.00. Following the transaction, the chief executive officer owned 1,132,987 shares in the company, […]